Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 70518-4506

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 70518-4506). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Orphenadrine Citrate extended-release tablets, 100 mg strength, containing 14 tablets. The label includes the NDC number 70518-4506-00 and shows the product is repackaged by RemedyRepack Inc., Indiana, PA. Additional storage and safety information is partially visible.*
FDA Label Image

Image (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 01)

Image (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 01)
Chemical structure of orphenadrine citrate, showing molecular arrangement of orphenadrine and citrate components as connected chemical groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.